Expression and stability of hypoxia inducible factor 1α in osteosarcoma

Pediatric Blood and Cancer

Volumn 59, Issue 7, 2012, Pages 1215-1222

  El Naggar, Amal ^a,b   Clarkson, Paul ^b   Zhang, Fan ^b   Mathers, Joan ^b   Tognon, Cristina ^a,b   Sorensen, Poul H ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

HIF1 stability; Hypoxia; Hypoxia inducible factor 1 (HIF1 ); Normoxia; Osteoblast, osteosarcoma

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SMALL INTERFERING RNA;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; OSTEOBLASTS; OSTEOSARCOMA; PROTEIN STABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84867385193     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24191     Document Type: Article

References (42)

1. Cohen NA, Lai SY, Ziober AF, et al. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential. Laryngoscope 2004; 114: 418- 423.
2. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230- 1237.
3. Poon E, Harris AL, Ashcroft M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 2009; 11: e26.
4. Mabjeesh NJ, Amir S. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol 2007; 22: 559- 572.
5. Krieg M, Haas R, Brauch H, et al. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000; 19: 5435- 5443.
6. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510- 5514.
7. Kim WY, Perera S, Zhou B, et al. HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice. J Clin Invest 2009; 119: 2160- 2170.
8. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721- 732.
9. Bertout JA, Patel SA, Fryer BH, et al. Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model. Cancer Res 2009; 69: 3213- 3220.
10. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271- 275.
11. Ohh M, Park CW, Ivan M, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2000; 2: 423- 427.
12. Tanimoto K, Makino Y, Pereira T, et al. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 2000; 19: 4298- 4309.
13. Huang LE. Carrot and stick: HIF-α engages c-Myc in hypoxic adaptation. Cell Death Differ 2008; 15: 672- 677.
14. 2 sensing. Science 2001; 292: 464- 468.
15. 2-regulated prolyl hydroxylation. Science 2001; 292: 468- 472.
16. Yu F, White SB, Zhao Q, et al. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 2001; 98: 9630- 9635.
17. Huang LE, Arany Z, Livingston DM, et al. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 1996; 271: 32253- 32259.
18. Maynard MA, Ohh M. The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci 2007; 64: 2170- 2180.
19. Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration. Proc Natl Acad Sci USA 2008; 105: 686- 691.
20. Chun YS, Kim MS, Park JV. Oxygen-dependent and -independent regulation of HIF1alpha. J Korean Med Sci 2002; 17: 581- 588.
21. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 2008; 412: 477- 484.
22. Mizobuchi H, García-Castellano JM, Philip S, et al. Hypoxia markers in human osteosarcoma: An exploratory study. Clin Orthop Relat Res 2008; 466: 2052- 2059.
23. Wu Q, Yang SH, Ye SN, et al. Therapeutic effects of RNA interference targeting HIF1 alpha gene on human osteosarcoma. Zhonghua Yi Xue Za Zhi 2005; 85: 409- 413.
24. Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor-1a renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 2001; 61: 6548- 6554.
25. Ryan HE, Poloni M, McNulty W, et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 2000; 60: 4010- 4015.
26. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005- 3015.
27. Trobisch P, Suess O, Schwab F. Idiopathic scoliosis. Dtsch Arztebl Int 2010; 107: 875- 884.
28. Kim JS, Lee HK, Kim MR, et al. Differentially expressed proteins of mesenchymal stem cells derived from human cord blood (hUCB) during osteogenic differentiation. Biosci Biotechnol Biochem 2008; 72: 2309- 2317.
29. Peppel K, Baglioni C. A simple and fast method to extract RNA from tissue culture cells. Biotechniques 1990; 9: 711- 713.
30. Mowat FM, Luhmann UF, Smith AJ, et al. HIF-1alpha and HIF-2alpha are differentially activated in distinct cell population in retinal ischaemia. PLoS ONE 2010; 5: e11103.
31. Sorokin AV, Selyutina AA, Skabkin MA, et al. Proteasome-mediated cleavage of the Y-box binding protein 1 is linked to DNA-damage stress response. EMBO J 2005; 24: 3602- 3612.
32. Ioannou M, Mylonis I, Kouvaras E, et al. Validated analysis of HIF-1alpha expression in cancer cells using a controlled and comparative immunoassay. Oncol Rep 2010; 24: 161- 169.
33. Evans DB, Bunning RA, Russell RG. The effects of recombinant human interleukin-1β on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Commun 1990; 166: 208- 216.
34. Araldi E, Schipani E. Hypoxia, HIFs and bone development. Bone 2010; 47: 190- 196.
35. Chau NM, Rogers P, Aherne W, et al. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1α induction in response to hypoxic stress and growth factors. Cancer Res 2005; 65: 4918- 4928.
36. Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830- 5835.
37. Wang Y, Wan C, Gilbert SR, et al. Oxygen sensing and osteogenesis. Ann N Y Acad Sci 2007; 1117: 1- 11.
38. Loboda A, Jozkowicz A, Dulak J. HIF1 and HIF2 transcription factors: Similar but not identical. Mol Cells 2010; 29: 435- 442.
39. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987- 7992.
40. Moroz E, Carlin S, Dyomina K, et al. Real-time imaging of HIF1α stabilization and degradation. PLoS ONE 2009; 4: e5077.
41. Chen WL, Feng HJ, Li HG. Expression and significance of hypoxemia-inducible factor-1alpha in osteosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 106: 254- 257.
42. Yang QC, Zeng BF, Shi ZM, et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. J Exp Clin Cancer Res 2006; 25: 593- 599.